Athira Pharma, Inc.
ATHA
$3.87
-$0.08-2.03%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 25.23M | 29.82M | 36.67M | 51.28M | 68.86M |
| Total Receivables | -- | -- | -- | -- | 1.63M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.80M | 2.40M | 3.18M | 3.57M | 3.15M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 8.37M |
| Total Current Assets | 27.03M | 32.22M | 39.85M | 54.84M | 82.00M |
|
|
|||||
| Total Current Assets | 27.03M | 32.22M | 39.85M | 54.84M | 82.00M |
| Net Property, Plant & Equipment | 2.32M | 2.63M | 2.94M | 3.25M | 3.56M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 686.00K | 693.00K | 716.00K | 686.00K | 686.00K |
| Total Assets | 30.03M | 35.55M | 43.51M | 58.78M | 86.25M |
|
|
|||||
| Total Accounts Payable | 266.00K | 171.00K | 867.00K | 319.00K | 388.00K |
| Total Accrued Expenses | 2.07M | 2.37M | 4.20M | 12.40M | 26.96M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 452.00K | 439.00K | 426.00K | 414.00K | 402.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 2.79M | 2.98M | 5.49M | 13.14M | 27.75M |
|
|
|||||
| Total Current Liabilities | 2.79M | 2.98M | 5.49M | 13.14M | 27.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 460.00K | 578.00K | 691.00K | 803.00K | 912.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 3.25M | 3.56M | 6.18M | 13.94M | 28.66M |
|
|
|||||
| Common Stock & APIC | 455.65M | 454.24M | 452.62M | 450.99M | 448.72M |
| Retained Earnings | -428.87M | -422.26M | -415.29M | -406.15M | -391.14M |
| Treasury Stock & Other | -2.00K | -3.00K | -4.00K | 1.00K | 3.00K |
| Total Common Equity | 26.79M | 31.99M | 37.33M | 44.84M | 57.58M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.79M | 31.99M | 37.33M | 44.84M | 57.58M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.79M | 31.99M | 37.33M | 44.84M | 57.58M |
|
|
|||||